HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $21 Price Target

Benzinga · 03/13 10:42
HC Wainwright & Co. analyst Vernon Bernardino reiterates Edesa Biotech (NASDAQ:EDSA) with a Buy and maintains $21 price target.